Cronos Group Inc (CRON)
$14.91
0.06 (0.40%)
CRON Stock Quote Delayed 15 Minutes
Previous Close
$14.97
Market Cap
2.63B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
708
Day's Range
14.86 - 15.33
52-Week Range
5.61 - 25.10
Dividend & Yield
N/A (N/A)
CRON Stock Predictions, Articles, and Cronos Group Inc News
I’m Glad I Don’t Own Cronos Group Stock and Here’s Why
Although CRON stock appears to be trading at a deep discount, prospective buyers should take into consideration the coming confluence of technical and fundamental headwinds.
Did Cronos Group Just Become a Big-Time Sell?
Although CRON stock has held up better than some of its peers, sector volatility appears ready to take it down too.
Does Aurora Cannabis Stock Chart Point to a Mid-Summer Plunge?
Aurora Cannabis stock broke down from a bearish technical setup last week. Can ACB repair the damage or are shares heading lower?
Even Cronos Isn’t Safe From the Pot Stock Implosion
The bloom is gone for the marijuana sector. Even the more conservative CRON stock is now feeling the side effects.
Cronos Needs to Show the Market Something to Pull Stock Out of Funk
CRON stock is putting pressure on the 200-day moving average line, as a floor, and Cronos Group can to little to relieve it.
Cronos Isn’t in a Rush. Investors in Cronos Stock Shouldn’t Be Either
Cronos is taking its time, which isn't a bad thing long-term. But it could be a near-term issue for CRON stock.
3 Reasons Cronos Group Stock Deserves A Buy Rating
Cronos currently has a market cap of $5.4 billion. In the first quarter, it closed the Altria investment. At the end of March, it had $1.8 billion in cash on the balance sheet. CRON stock is trading at less than 3x cash.
Expect More Dips, Less Rips in Canopy Growth Stock
Canopy Growth (CGC) is poised to dominate the American cannabis market. But after a weak earnings report, its current sky-high valuation is in question.
What Is Good For Cronos Group Will Likely Not Benefit Cronos Stock
Cronos Group should benefit from the Altria investment and the growth of the cannabis industry, but CRON stock will struggle to benefit.
Monday’s Vital Data: Canopy Growth Corp, Microsoft and Netflix
Options trading was buzzing in Canopy Growth, Microsoft and Netflix. Here are the metrics that matter moving forward.
Why Cronos Group Stock Still Looks Overvalued
CRON stock is the most richly valued stock in one of the most richly valued sectors, and the risk-reward ratio of Cronos stock is negative..
The Blue Chip of Pot: Can CGC Stock Rally 20% on Acreage Deal and Earnings?
CGC stock will report earnings on June 20th, just a day after it got the OK from shareholders for its $3.4 billion deal for Acreage Holdings.
After a Bumpy Few Months, Cronos Stock Is Back on the Move
Cronos may have $2 billion in cash but it is strategic in the way it spends that. So far the right moves are helping Cronos stock.
CGC Stock Continues Week of Losses for Pot Stocks
Thursday’s 2.29% slide in CGC stock price reflects uncertainty about Canopy Growth’s forthcoming Q4 2019 results, cannabis market volatility.
Cronos Group Stock Is Just Getting Started
CRON stock has a solid band of support so the bulls can mount a 20% rally from here. The bears are at a disadvantage.
Cronos Stock Could Be Worth the Bumpy Ride
This month, Cronos stock seems to have found round number support at $14 and is rallying hard off that level.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
A
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
